Morbidity following transcrestal and lateral sinus floor elevation: A randomized trial

J Clin Periodontol. 2018 Sep;45(9):1128-1139. doi: 10.1111/jcpe.12985. Epub 2018 Aug 3.

Abstract

Aim: To comparatively evaluate the morbidity following maxillary sinus floor elevation according to either transcrestal (tSFE) or lateral (lSFE) approach with concomitant implant placement.

Materials & methods: Patients with ≥1 edentulous maxillary posterior site with residual bone height (RBH) of 3-6 mm were enrolled. tSFE was performed in association with a xenograft and a collagen matrix. For lSFE, the sinus was grafted with the xenograft, and the antrostomy was covered with a membrane. Implants were inserted concomitantly. The postoperative course was assessed through questionnaires. Pain level (VASpain ) was recorded using a 100-mm visual analogue scale.

Results: Twenty-nine and 28 patients were included in tSFE and lSFE group, respectively. On the day of surgery, VASpain was significantly higher for tSFE compared to lSFE, and similar from day 1 to 14. tSFE was characterized by significantly lower incidence of swelling, bruising and nasal discharge/bleeding. Significantly less severe limitation in swallowing, continuing daily activities, eating, speaking, opening the mouth and going to school/work was found for tSFE only at specific postsurgery intervals.

Conclusions: lSFE was associated with lower pain on the day of surgery, and tSFE revealed lower postoperative morbidity as well as more tolerable postoperative course.

Trial registration: ClinicalTrials.gov NCT02415946.

Keywords: alveolar process; bone regeneration; bone resorption; dental implants; maxillary sinus; minimally invasive; spiral cone-beam computed tomography; surgical procedures; tooth extraction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dental Implantation, Endosseous
  • Dental Implants*
  • Humans
  • Incidence
  • Maxilla
  • Maxillary Sinus
  • Sinus Floor Augmentation*

Substances

  • Dental Implants

Associated data

  • ClinicalTrials.gov/NCT02415946